Madrigal Pharmaceuticals (MDGL) Profit After Tax: 2009-2025
Historic Profit After Tax for Madrigal Pharmaceuticals (MDGL) over the last 12 years, with Sep 2025 value amounting to -$114.2 million.
- Madrigal Pharmaceuticals' Profit After Tax fell 6.76% to -$114.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$289.1 million, marking a year-over-year increase of 44.25%. This contributed to the annual value of -$465.9 million for FY2024, which is 24.70% down from last year.
- According to the latest figures from Q3 2025, Madrigal Pharmaceuticals' Profit After Tax is -$114.2 million, which was down 170.07% from -$42.3 million recorded in Q2 2025.
- In the past 5 years, Madrigal Pharmaceuticals' Profit After Tax registered a high of -$42.3 million during Q2 2025, and its lowest value of -$152.0 million during Q2 2024.
- In the last 3 years, Madrigal Pharmaceuticals' Profit After Tax had a median value of -$98.7 million in 2023 and averaged -$97.2 million.
- Per our database at Business Quant, Madrigal Pharmaceuticals' Profit After Tax plummeted by 91.87% in 2024 and then spiked by 72.18% in 2025.
- Quarterly analysis of 5 years shows Madrigal Pharmaceuticals' Profit After Tax stood at -$64.5 million in 2021, then plummeted by 33.08% to -$85.9 million in 2022, then slumped by 30.60% to -$112.2 million in 2023, then soared by 47.03% to -$59.4 million in 2024, then dropped by 6.76% to -$114.2 million in 2025.
- Its Profit After Tax stands at -$114.2 million for Q3 2025, versus -$42.3 million for Q2 2025 and -$73.2 million for Q1 2025.